货号:GS40767
Urtoxazumab is a humanized monoclonal antibody targeting the Shiga toxin 2 (Stx2) produced by Shiga toxin-producing Escherichia coli (STEC). It binds to and neutralizes Stx2, preventing toxin-mediated endothelial damage and reducing the risk of severe complications such as hemolytic uremic syndrome (HUS). It is being developed for the treatment of STEC infections, particularly in pediatric patients.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯